Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis Geography
AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® IN GENERALIZED MYASTHENIA GRAVIS AT AANEM 2024 Life Science Investing
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares Geography
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys
